EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities

Xiaoyu Zhang, Hao Sun, Biaoxu Tao, Ziyang Li iD, Shuning Liu iD, Haojie Zhang, Chang Liu iD, Jiatong Wang

Nutrients · 2026

DOI: 10.3390/nu18183066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Xiaoyu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Sports Training, Wuhan Sports University, Wuhan 430079, China. Hauptthemen laut MEDLINE: Obesity, ortho-Aminobenzoates, Avena, Metabolic Diseases. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Peking University Health Science Center, Fundamental Research Funds, Peking University Medical–Qingyan Boshi Joint Laboratory for Skin Nutrition and Anti-Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity-related metabolic dysfunction includes adipose inflammation, hepatic steatosis, insulin resistance, dyslipidemia, and intestinal disturbances. Avenanthramides are oat-specific phenolic amides, and their contribution to metabolic responses to oat foods is difficult to attribute because beta-glucan and the wider oat matrix can affect the same endpoints. This narrative review examines their mechanisms, exposure biology, evidence attribution, and translational readiness.

Methods

Cell, animal, pharmacokinetic, and human studies were organized by chemical definition and intervention format, including purified congeners, characterized foods, enriched matrices, and whole-oat products. Parent compounds, circulating metabolites, target tissues, and clinical outcomes were interpreted separately.

Results

In cell and animal models, avenanthramides influence NF-κB-related inflammation, redox regulation, hepatic insulin signaling, glucose production, fatty-acid metabolism, and intestinal ecology. Human studies demonstrate dietary exposure to parent compounds and metabolites, while clinical evidence comes mainly from small enriched-food exercise studies. Among the studies identified and appraised in this narrative review, none established an avenanthramide-specific effect on adiposity, liver fat, insulin sensitivity, dyslipidemia, or other cardiometabolic outcomes.

Conclusions

The current literature supports measurable exposure and candidate mechanisms; a validated anti-obesity effect requires targeted clinical trials. Next studies need stable, analytically defined preparations, metabolite-informed dose selection, matched food controls, and trials that link measured exposure with prespecified clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesityortho-AminobenzoatesAvenaMetabolic DiseasesHumansAnimalsInsulin ResistanceTranslational Research, Biomedical

Stichwörter der Autor:innen

avenanthramidesgut microbiotahepatic steatosisinsulin resistancelipid metabolismmetabolic inflammationoatsobesity

Substanzen

ortho-Aminobenzoatesavenanthramide-2C

Autor:innen und Institutionen

  • School of Sports Training, Wuhan Sports University, Wuhan 430079, China.
  • School of Sports Science, Beijing Sport University, Beijing 100084, China.
  • Department of Sports Journalism and Management, Henan Sport University, Zhengzhou 450044, China.

ORCID-Profile: Ziyang Li, Shuning Liu, Chang Liu

Förderung

  • the Peking University Health Science Center
  • Fundamental Research Funds
  • Peking University Medical–Qingyan Boshi Joint Laboratory for Skin Nutrition and Anti-Aging
  • Peking University Health Science Center
  • Youth Program of the Ministry of Education, Humanities, and Social Sciences Fund
  • Beijing Higher Education Society’s Sub-Committee on University Student Employment and Entrepreneurship Research
  • BSU Project
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, X., Sun, H., Tao, B., Li, Z., Liu, S., Zhang, H., Liu, C., & Wang, J. (2026). Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities. Nutrients. https://doi.org/10.3390/nu18183066

Vancouver

Zhang X, Sun H, Tao B, Li Z, Liu S, Zhang H, et al. Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities. Nutrients. 2026. doi:10.3390/nu18183066

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaoyu and Sun, Hao and Tao, Biaoxu and Li, Ziyang and Liu, Shuning and Zhang, Haojie and Liu, Chang and Wang, Jiatong},
  title = {Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18183066}
}
Kostenlos starten →